From the publishers of JADPRO

MPN Resource Center

Advertisement

Treatment options and pregnancy management for patients with PV and ET

Last Updated: Friday, September 2, 2022

This review article highlights current treatment options for patients with polycythemia vera and essential thrombocythemia, including hydroxyurea and newer agents—JAK, HDAC, LSD1, and MDM2 inhibitors, and hepcidin mimetics—as well as approaches for managing pregnancy during treatment.

International Journal of Hematology
Advertisement
News & Literature Highlights
Advertisement
Advertisement